GH was 79% significantly lower in subjects with the cluster of four MetS risk factors in comparison to subjects without the cluster of four MetS risk factors(mean difference = 756.9 pg/mL, p = 0.001) (Fig. 3D). This evidence concerns the gene GH1 and metabolic syndrome.